Western companies seem to be heading out of China in droves, but one pharmaceutical giant is buying in.
U.S. drugmaker Moderna just inked a new deal to make mRNA medicines in China.
But there’s one key factor: “Any medicines produced under this agreement will be exclusively for the Chinese people… and will not be exported,” according to a Moderna statement sent to CNN.
The move marks the biotech company’s first major investment in the country.